CXM Form 144: Insider Plans Sale of 370,734 Shares on NYSE

Rhea-AI Filing Summary

Notice of proposed sale of common stock by an insider. The filer intends to sell 370,734 shares of common stock on 10/06/2025 with an aggregate market value of $2,900,000.00. These shares represent part of an issuer-originated holding acquired on 06/26/2020 by purchase from the issuer with cash payment. The filing reports 270,400,000 shares outstanding for the company and indicates no sales of the issuer's securities by the same person in the past three months. The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information.

Positive

• Insider complied with Rule 144 notice requirements by filing a Form 144 with broker and sale date
• Aggregate sale size is modest at $2.9M, approximately 0.14% of outstanding shares

Negative

• Filing does not state a Rule 10b5-1 trading plan adoption date, so plan-based safe harbor is not documented
• Insider attests no undisclosed material adverse information, but no additional disclosure is provided to corroborate that attestation

Insights

Securities Compliance Analyst

Form 144 documents a planned Rule 144 sale and standard insider attestation.

The filing shows a proposed sale under Rule 144 of 370,734 common shares, filed using the broker Raymond James & Associates, and lists the intended execution date as 10/06/2025. The filer certifies no knowledge of undisclosed material adverse information, which is a required statement under the form.

Key compliance items to confirm are whether volume, holding-period and notice thresholds for Rule 144 are met and that any trading plan (e.g., Rule 10b5-1) is disclosed if relied upon; the filing does not state a trading plan adoption date.

Equity Market Analyst

The proposed sale equals a small fraction of total shares outstanding.

The block of 370,734 shares equals roughly 0.14% of the reported 270,400,000 shares outstanding, so direct market impact should be limited absent other concurrent selling. The broker and exchange (NYSE) are specified, which clarifies execution channels.

Investors monitoring supply should note the 10/06/2025 planned sale date and the $2.9M aggregate value as near‑term liquidity that could modestly increase float on that date.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	RAYMOND JAMES & ASSOCIATES 880 Carillon Parkway St. Petersburg FL 33716	370734	2900000.00	270400000	10/06/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/26/2020	PURCHASE	ISSUER			370734	06/26/2020	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Sprinklr (CXM) Form 144 disclose?

It discloses a proposed sale of 370,734 common shares valued at $2,900,000.00, to be sold on 10/06/2025 via Raymond James on the NYSE.

How much of CXM's outstanding stock is included in this Form 144 sale?

The filing shows 270,400,000 shares outstanding, so the 370,734 shares represent about 0.14% of outstanding shares.

When were the shares acquired that are being sold?

The shares were acquired on 06/26/2020 by purchase from the issuer with cash payment.

Does the Form 144 report other sales in the past three months?

No. The filing indicates "Nothing to Report" for securities sold during the past three months by the same person.

Is there a 10b5-1 trading plan mentioned in this filing?

No. The filing includes the standard notice about trading plans but does not list a plan adoption date or statement that one exists.